AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic.
Read MoreDr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), a member of ACIP’s COVID-19 Vaccine Workgroup, and chair-elect of the AMA Board of Trustees, shares details from the latest ACIP meeting, including more details on the Pfizer approval, the latest vaccine safety data and the timeline for booster shots.
Read MoreA discussion with Sandra Fryhofer, MD, chair-elect of the AMA Board of Trustees and the AMA’s liaison to the Advisory Committee on Immunization Practices, about if and when we’ll need COVID-19 vaccine boosters, the role of the dangerous Delta variant and how this all affects immunocompromised individuals.
Read MoreA discussion with Dr. Sandra Fryhofer, the AMA’s liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), who takes a closer look at the delta variant and other variants of concern. She also covers what physicians need to know about authorized COVID vaccines, including real-world effectiveness and rare adverse events.
Read MoreFriend of the show, Dr. Sandra Fryhofer—the AMA liaison to the CDC’s Advisory Committee on Immunization Practices and the AMA’s representative on the COVID-19 vaccine work group—joins us for a quick and comprehensive look at the emerging details regarding the J&J/Janssen COVID-19 vaccine.
Read More
Comentarios recientes